Grab (GRAB) vs HealthEquity (HQY)
Head-to-head comparison of performance, valuation, growth, profitability and dividends. Prices delayed 15 minutes; data as of Nov 22, 2026.
Summary
HealthEquity (HQY) has outperformed Grab (GRAB) over the past year, losing 7.0% versus a loss of 43.9%. Over five years, HQY leads with a +65.1% price change compared with -79.2% for GRAB. Grab is the larger company by market cap ($11.10 billion vs $7.84 billion), about 1.4 times the size.
On valuation, HealthEquity trades at a lower forward P/E (17.2x vs 17.5x for Grab). HealthEquity converts more of its revenue into profit, with a net margin of 16.4% versus 8.0%.
Summary generated from market data by MetaCap's automated system. Methodology
Relative performance
Percent change in share price from the first common trading day shown; excludes dividends.
Head-to-head
| Metric | GRAB | HQY |
|---|---|---|
| Share price | $2.75 | $94.75 |
| Market cap | $11.10B | $7.84B |
| 1-day change | -6.14% | -2.70% |
| YTD return | -44.89% | +3.43% |
| 1-year return | -43.88% | -7.03% |
| 5-year return | -79.25% | +65.10% |
| P/E ratio (TTM) | 27.50 | 34.21 |
| Forward P/E | 17.52 | 17.17 |
| EPS (TTM) | $0.10 | $2.77 |
| Dividend yield | 0.00% | 0.00% |
| Annual dividend | $0.00 | $0.00 |
| Revenue (latest FY) | $3.37B | $1.31B |
| Revenue growth (YoY) | +20.49% | +9.47% |
| Net income (latest FY) | $268.00M | $215.20M |
| Gross margin | 43.20% | 69.52% |
| Operating margin | 1.93% | 24.55% |
| Net margin | 7.95% | 16.38% |
| 52-week high | $5.50 | $110.26 |
| 52-week low | $2.67 | $72.76 |
| Distance from 52-week high | -50.00% | -14.07% |
| Analyst consensus | strong_buy | none |
| Avg. price target upside | +96.00% | +27.36% |
| Average volume | 71.25M | 886.63K |
| Shares outstanding | 3.94B | 82.72M |
| Employees | 12,012 | 2,814 |
| Sector | Consumer Discretionary | Consumer Discretionary |
| Industry | Business Services | Business Services |
Highlighted cells mark the higher value for growth, returns, margins and yield, and the lower value for P/E ratios. Highlighting is a mechanical comparison, not a recommendation.
Key differences
- HQY has outperformed GRAB by 36.9 percentage points over the past year.
- HealthEquity is more profitable, keeping 16.4 cents of every revenue dollar as net income versus 8.0 cents for Grab.
- Grab grew revenue faster in its latest fiscal year (+20.49% vs +9.47%).
About Grab
GRAB stock →Grab Holdings Limited operates the Grab superapp in Cambodia, Indonesia, Malaysia, Myanmar, the Philippines, Singapore, Thailand, and Vietnam. The company offers delivery services on its platform, such as GrabFood, a food ordering and delivery booking service; Dine-Out for table reservations; GrabMart, a goods ordering and delivery booking service; GrabAds, an online advertising solution; GrabExpress, a package delivery booking service; Grab for Business platform, a unified management portal for corporate clients.
Consumer Discretionary · Business Services · 12,012 employees
About HealthEquity
HQY stock →HealthEquity, Inc. provides technology-enabled services platforms to consumers and employers in the United States.
Consumer Discretionary · Business Services · 2,814 employees
GRAB vs HQY FAQ
Which is bigger, Grab or HealthEquity?
Grab (GRAB) is larger, with a market capitalization of $11.10B compared with $7.84B for HealthEquity (HQY).
Which stock has performed better over the past year, GRAB or HQY?
HQY returned -7.03% over the past 12 months, compared with -43.88% for GRAB (price return, excluding dividends). Past performance does not predict future results.
Which has the lower P/E ratio, GRAB or HQY?
GRAB has the lower trailing P/E at 27.5, versus 34.2 for HQY. A lower P/E is not by itself a sign of a better investment; it can reflect slower expected growth or higher risk.
Are Grab and HealthEquity in the same industry?
Yes. Both are classified in the Business Services industry within the Consumer Discretionary sector.